Idursulfase
HGT-ELA-038
Approved mab completed
Quick answer
Idursulfase for Hunter Syndrome is a Approved program (mab) at Takeda with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda
- Indication
- Hunter Syndrome
- Phase
- Approved
- Modality
- mab
- Status
- completed